Kyanos

Toulouse, France Founded: 2016 • Age: 10 yrs
Developer of microalgae-based supplements for multiple health ailments

About Kyanos

Kyanos is a Healthcare company based in Toulouse (France) founded in 2016 by Vinh Ly. Developer of microalgae-based supplements for multiple health ailments. Kyanos has raised $3.14 million across 3 funding rounds from investors including European Union and EIC Fund. Its chief executive, as recorded, is Vinh Ly. Kyanos offers products and services including Aphanizomenon flos-aquae and Microalgae-based Protein. Its focus areas include Life Sciences, Nutraceuticals Tech, Dietary Supplements and Disease Specific. Its legal entity is Kyanos Biotechnologies.

Company details

Kyanos was founded in 2016 in Toulouse, France, within the biotechnology sector. Microalgae-based dietary supplements are developed by the company to address immune health, sports performance, energy levels, focus, and skincare needs. Research and technology are leveraged in operations to produce these supplements, with a focus on natural ingredients derived from microalgae. The domain kyanos.bio is utilized for online presence.

  • Headquarters Toulouse, France
  • Founders Vinh Ly
  • Sectors
    Healthcare
  • Website kyanos.bio
  • Social LinkedIn Facebook
  • Legal Name Kyanos Biotechnologies
Key Metrics
  • Total Equity Funding
    $3.14M (USD)

    in 3 rounds

  • Latest Funding Round
    $3.14M (USD), Series A

    May 2021

  • Investors

Products & Services of Kyanos

Kyanos offers a comprehensive portfolio of products and services, including Aphanizomenon flos-aquae and Microalgae-based Protein.

Aphanizomenon flos-aquae
Microalgae Ingredient

Sustainable microalgae for nutritious protein in food systems.

Microalgae-based Protein
Sustainable Food Product

Nutritive protein source with reduced environmental impact.

Funding Insights of Kyanos

Kyanos has successfully raised a total of $3.14M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $3.14 million completed in May 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $3.14M
  • Total Rounds 3
  • Last Round Series A β€” $3.14M
  • First Round $56,002

    (May 2019)

  • Investors Count 2

All 3 funding rounds of Kyanos with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2021$3.14MSeries A––
–
Oct 2019$55,601Grant––
May 2019$56,002Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in Kyanos

Kyanos has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and EIC Fund.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Government agency and accelerator focusing on innovative startups and SMEs
eicfund.euBrussels, Belgium
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for Kyanos

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Kyanos

1 people are tracked at Kyanos (1 in leadership).

NameRoleGroup
Vinh Ly
Founder & CEOLeadership
Premium access

Complete people profiles for Kyanos

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Kyanos

3 dated milestones of Kyanos across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Kyanos is founded.
  2. Funding First funding round of $56K.
  3. Funding Latest funding round, Series A, of $3.1M.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Kyanos

Kyanos Biotechnologies’ €2,6 Million Funding
Globallegalchronicle β€’ 5 years ago
Premium access

Complete news archive for Kyanos

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kyanos

Kyanos was founded in 2016 and raised its 1st funding round 3 years after it was founded.

Kyanos is headquartered in Toulouse, France. It is registered at Toulouse, Occitanie, France.

Vinh Ly is the CEO of Kyanos, as recorded in our data. They have also founded this company.

Kyanos is a funded company, having raised a total of $3.14M across 3 funding rounds to date. The company's 1st funding round was a Grant of $56K, raised on May 2019.

Kyanos was founded in 2016 in Toulouse, France, within the biotechnology sector. Microalgae-based dietary supplements are developed by the company to address immune health, sports performance, energy levels, focus, and skincare needs. Research and technology are leveraged in operations to produce these supplements, with a focus on natural ingredients derived from microalgae. The domain kyanos.bio is utilized for online presence.

Kyanos offers Aphanizomenon flos-aquae and Microalgae-based Protein.

Kyanos has 2 investors. Key investors include European Union, and EIC Fund.

Kyanos operates through Kyanos Biotechnologies.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available